Current Pharmaceutical Design
Title: Preface
Volume: 8 Issue: 18
Author(s): Nestor O. Concha
Affiliation:
Export Options
About this article
Cite this article as:
Concha O. Nestor, Preface, Current Pharmaceutical Design 2002; 8 (18) . https://dx.doi.org/10.2174/1381612023394160
DOI https://dx.doi.org/10.2174/1381612023394160 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of Proteasome Inhibitors on the AAV-Mediated Transduction Efficiency in Retinal Bipolar Cells
Current Gene Therapy Recent Advances in Porphyrin-Derived Sensors
Current Organic Chemistry Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection
Current Medicinal Chemistry Extracellular ATP and Neurodegeneration
Current Drug Targets - CNS & Neurological Disorders Complications of Anti-Vascular Endothelial Growth Factor Drugs
Current Drug Therapy Detection of Tumor Markers with ProteinChip® Technology
Current Pharmaceutical Biotechnology Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets The Discovery of Antiangiogenic Molecules: A Historical Review
Current Pharmaceutical Design Immune Response to Herpes Simplex Virus and γ134.5 Deleted HSV Vectors
Current Gene Therapy Walking the Oxidative Stress Tightrope: A Perspective from the Naked Mole-Rat, the Longest-Living Rodent
Current Pharmaceutical Design HPLC and MS Analysis for the Identification and Characterisation of Peptides Presented in the Context of the Non-Classical Human Leukocytes Antigen (HLA) Class I Molecule HLA-E
Current Pharmaceutical Design The Evidence for Automated Grading in Diabetic Retinopathy Screening
Current Diabetes Reviews Factors Driving the Choice of the Best Second-Line Treatment of Advanced NSCLC
Reviews on Recent Clinical Trials Clinical Application of Ghrelin
Current Pharmaceutical Design Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Drug Delivery Systems for Photodynamic Therapy
Recent Patents on Drug Delivery & Formulation Drosophila Renal Organ as a Model for Identification of Targets and Screening of Potential Therapeutic Agents for Diabetic Nephropathy
Current Drug Targets Quantitative Enzymology
Current Enzyme Inhibition Pluripotent Stem Cell-Derived Somatic Stem Cells as Tool to Study the Role of MicroRNAs in Early Human Neural Development
Current Molecular Medicine